Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Acoust Soc Am ; 146(4): 2350, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31671949

RESUMO

Monitoring mechanical systems operating in uncertain environments contaminated with both environmental disturbances and noise lead directly to low signal-to-noise-ratios, creating an extremely challenging processing problem, especially in real-time. In order to estimate the performance of a particular system from uncertain vibrational data, it is necessary to identify its unique resonant (modal) frequency signature. The monitoring of structural modes to determine the condition of a device under investigation is essential, especially if it is a critical entity of an operational system. The development of a model-based scheme capable of the on-line tracking of the inherent structural modal frequencies by applying both constrained subspace identification techniques to extract the modal frequencies and state estimation methods to track the evolution is discussed. An application of this approach to a cylindrical structural device (pipe-in-air) is analyzed based on theoretical simulations along with controlled validation experiments, including injected anomalies illustrate the approach and performance. Statistics are gathered to bound potential processors for real-time performance employing these constrained techniques.

2.
Pharmacology ; 18(5): 235-40, 1979.
Artigo em Inglês | MEDLINE | ID: mdl-482344

RESUMO

Spironolactone, a competitive inhibitor of mineralocorticoid effects on the distal tubule of the kidney, has recently been found to have other metabolic effects. In these studies, spironolactone (200mg/kg intraperitoneally) for 3 days was found to have a marked protective effect against the hepatotoxic effect of D-galactosamine (275 mg/kg) in rats. Further progress in defining the mechanism of protection from D-galactosamine hepatic necrosis by spironolactone will require assessment of effects of spironolactone on uridine nucleotide metabolism.


Assuntos
Galactosamina/antagonistas & inibidores , Fígado/efeitos dos fármacos , Espironolactona/farmacologia , Animais , Aspartato Aminotransferases/sangue , Ácidos e Sais Biliares/sangue , Galactosamina/farmacologia , Injeções Intraperitoneais , Fígado/metabolismo , Fígado/patologia , Masculino , Necrose/induzido quimicamente , Ratos , Espironolactona/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA